Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
1268.17
Headquarter in Copenhagen and 15 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 2 EP applications Casper Struve has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 5, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11749558

PROCESS FOR THE PREPARATION OF ZANAMIVIR

IPC classification:
C07D 309/28
Agent:
Casper Struve, Zacco Denmark A/S
Agent:
Maria Helena Danielsson, Zacco Sweden AB
Status:
GRANT OF PATENT INTENDED
EP11767077

SUBSTITUTED 4-(4-FLUORO-3-(PIPERAZINE-1- CARBONYL)BENZYL)PHTHALAZIN-1(2H)-ONE DERIVATIVES AS POLY (ADP-RIBOSE) POLYMERASE- 1 INHIBITORS

IPC classification:
A61K 31/502, A61P 35/00, C07D 237/32, C07D 403/12
Applicant:
Cadila Healthcare Ltd
Agent:
Casper Struve, Zacco Denmark A/S
Agent:
Renzo Christiaan Verboom, Zacco Sweden AB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature